Banque Pictet & Cie SA boosted its stake in HCA Holdings, Inc. (NYSE:HCA) by 73.9% during the first quarter, according to its most recent filing with the SEC. The firm owned 67,235 shares of the company’s stock after buying an additional 28,562 shares during the period. Banque Pictet & Cie SA’s holdings in HCA Holdings were worth $5,983,000 as of its most recent SEC filing.
Several other large investors have also recently modified their holdings of HCA. Orbimed Advisors LLC boosted its stake in shares of HCA Holdings by 52.6% in the fourth quarter. Orbimed Advisors LLC now owns 2,002,200 shares of the company’s stock valued at $148,203,000 after buying an additional 690,000 shares during the period. Three Bays Capital LP purchased a new stake in shares of HCA Holdings during the fourth quarter valued at about $36,766,000. Levin Capital Strategies L.P. boosted its stake in shares of HCA Holdings by 10.5% in the fourth quarter. Levin Capital Strategies L.P. now owns 10,500 shares of the company’s stock valued at $777,000 after buying an additional 1,000 shares during the period. A.R.T. Advisors LLC boosted its stake in shares of HCA Holdings by 47.6% in the fourth quarter. A.R.T. Advisors LLC now owns 30,680 shares of the company’s stock valued at $2,270,000 after buying an additional 9,900 shares during the period. Finally, Blenheim Capital Management BV purchased a new stake in shares of HCA Holdings during the fourth quarter valued at about $207,000. 75.36% of the stock is currently owned by hedge funds and other institutional investors.
Shares of HCA Holdings, Inc. (NYSE:HCA) traded down 0.72% during mid-day trading on Tuesday, hitting $84.00. The stock had a trading volume of 828,664 shares. The stock’s 50-day moving average is $83.39 and its 200 day moving average is $82.28. The firm has a market cap of $30.82 billion, a PE ratio of 11.41 and a beta of 0.77. HCA Holdings, Inc. has a 12 month low of $67.00 and a 12 month high of $91.03.
HCA Holdings (NYSE:HCA) last released its quarterly earnings data on Tuesday, May 2nd. The company reported $1.74 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.74. The business had revenue of $10.62 billion during the quarter, compared to analysts’ expectations of $10.64 billion. HCA Holdings had a net margin of 6.70% and a negative return on equity of 45.28%. The company’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same period in the previous year, the company earned $1.71 EPS. Equities research analysts predict that HCA Holdings, Inc. will post $7.38 earnings per share for the current fiscal year.
Several equities research analysts have recently issued reports on the company. Zacks Investment Research cut HCA Holdings from a “buy” rating to a “hold” rating in a report on Tuesday, March 28th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $95.00 target price on shares of HCA Holdings in a report on Monday, April 17th. Deutsche Bank AG assumed coverage on HCA Holdings in a report on Tuesday, April 4th. They issued a “buy” rating and a $103.00 target price on the stock. Mizuho raised HCA Holdings from a “neutral” rating to a “buy” rating and set a $98.00 target price on the stock in a report on Monday, March 27th. Finally, BidaskClub raised HCA Holdings from a “strong sell” rating to a “sell” rating in a research note on Tuesday, June 13th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and twelve have issued a buy rating to the company. HCA Holdings has an average rating of “Buy” and an average target price of $92.44.
In other news, SVP Jana Joustra Davis sold 8,302 shares of HCA Holdings stock in a transaction on Thursday, May 11th. The shares were sold at an average price of $85.02, for a total transaction of $705,836.04. Following the completion of the sale, the senior vice president now directly owns 36,589 shares of the company’s stock, valued at approximately $3,110,796.78. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, major shareholder Thomas F. Frist, Jr. acquired 361,205 shares of the firm’s stock in a transaction dated Friday, May 5th. The shares were purchased at an average cost of $83.06 per share, with a total value of $30,001,687.30. Following the completion of the transaction, the insider now owns 167,000 shares in the company, valued at approximately $13,871,020. The disclosure for this purchase can be found here. Over the last ninety days, insiders have sold 358,317 shares of company stock valued at $29,996,336. Corporate insiders own 2.90% of the company’s stock.
About HCA Holdings
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.